tryptanthrine has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, J; Lai, D; Luo, C; Shen, X; Zeng, Q; Zhang, X; Zhou, W | 1 |
| Chen, TM; Chen, YH; Chern, JW; Tseng, SY; Yu, ST | 1 |
2 other study(ies) available for tryptanthrine and Adenocarcinoma
| Article | Year |
|---|---|
Tryptanthrin exerts anti-breast cancer effects both in vitro and in vivo through modulating the inflammatory tumor microenvironment.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Mice; Mice, Inbred BALB C; Quinazolines; Tumor Microenvironment | 2021 |
Downregulation of GSTpi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Enzyme Induction; Female; Glutathione S-Transferase pi; Humans; JNK Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Protein Binding; Protein Processing, Post-Translational; Quinazolines | 2009 |